Odan Laboratories Recalls Dry to Normal Skin Starter Kit for Stability Failure
Odan Laboratories is recalling 179 kits of Dry to Normal Skin Starter Kit because the product failed stability specifications at 12 months.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The specific defect is a stability failure, which is a quality control issue rather than a direct contamination or acute hazard like a high-risk pathogen or structural defect.
Plain-English summary
Odan Laboratories Ltd is recalling 179 units of the Dry to Normal Skin Starter Kit (Trousse debutante pour peau seche a normale). The kit includes a Vegetable Cleanser, Night Cream, Day Cream SPF15, and Eye Cream. The product was distributed nationwide in the USA.
The recall was initiated because the product failed stability specifications, specifically showing a stability failure at 12 months under long-term room temperature conditions. The affected lots are # J203, J204 (EXP 02-2018) and # J228, J274 (EXP 09-2018). The product was manufactured in Canada by Kamins Dermatologics Inc. and distributed by Kamins Dermatologics (USA) Inc.
Consumers who have purchased this product should stop using it and contact the recalling firm for instructions on how to return or dispose of the product.
The recalled product
- Product
- Dry to Normal Skin Starter Kit, Trousse debutante pour peau seche a normale. Kit includes: (Vegetable Cleanser (60 ml / 2 oz), Night Cream (15 g / 0.5 oz), Day Cream SPF15 {Octinoxate 7%, Avobenzone 2% and Oxybenzone 5%} (15 g / 0.5 oz), Eye Cream (6 g / 0.21 oz).Made in…
- Manufacturer
- Odan Laboratories Ltd
- Category
- Drug — Topical Dermatology
- Hazard
- Affected units
- 179
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots # J203
- J204
- EXP 02-2018
- J228
- J274
- EXP 09-2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Odan Laboratories Ltd under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Odan Laboratories Ltd
See all →- ModerateOdan Laboratories Recalls Day Cream SPF15 Due to Stability Failure
FDA (Drugs) · 2018-01-31
Same hazard · stability failure
See all →- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
Similar recalls
- LowEstee Lauder DayWear Moisturizer Recalled for Potential Sunscreen Instability
FDA (Drugs) · 2013-02-13
- ModerateOculus Recalls Ceramax Skin Barrier Cream Professional Samples
FDA (Devices) · 2016-12-21
- ModerateEb5 Age Spot Treatment Cream Recalled for Stability Failures
FDA (Drugs) · 2018-07-11
- ModerateLa Roche-Posay Effaclar Acne Treatment Kits Recalled Nationwide
FDA (Drugs) · 2025-05-21
- Moderatevite20 Antifungal Cream recalled due to stability testing deviations
FDA (Drugs) · 2026-07-08
- ModerateAkorn Recalls Desoximetasone Ointment for Stability Failures
FDA (Drugs) · 2016-11-30